Mild hemophilia A patient with novel Pro1809Leu mutation develops an anti‐C2 antibody inhibiting allogeneic but not autologous factor VIII activity

Publisher： John Wiley & Sons Inc

E-ISSN： 1538-7836|1538-7933|10|1843-1853

ISSN： 1538-7933

Source： JOURNAL OF THROMBOSIS AND HAEMOSTASIS, Vol.1538-7933, Iss.10, 2015-10, pp. : 1843-1853

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Factor VIII-von Willebrand Factor Binding Defects in Autosomal Recessive von Willebrand Disease Type Normandy and in Mild Hemophilia A

By  

Acta Haematologica, Vol. 121, Iss. 2-3, 2009-06 ,pp. : 102-105

Karger

Access to resources Recommend Favorite

Factor VIII Inhibitors in Patients with Hemophilia A

By  

Acta Haematologica, Vol. 102, Iss. 1, 1999-09 ,pp. : 42-46

Karger

Access to resources Recommend Favorite

Half‐life extended factor VIII for the treatment of hemophilia A

By  

JOURNAL OF THROMBOSIS AND HAEMOSTASIS, Vol. 13, Iss. S1, 2015-06 ,pp. : S176-S179

John Wiley & Sons Inc

Access to resources Recommend Favorite

Functional Analysis of the Factor IX Epidermal Growth Factor-Like Domain Mutation Ile66Thr Associated with Mild Hemophilia B

By  

Pathophysiology of Haemostasis and Thrombosis, Vol. 35, Iss. 5, 2007-01 ,pp. : 370-375

Karger

Access to resources Recommend Favorite

Successful Management of Massive Intraperitoneal Bleeding in a Hemophilia A Patient with Inhibitor by Surgical Debridement of the Incomplete Hematoma and Administration of Recombinant Factor VIII and Activated Factor VII

By  

Pathophysiology of Haemostasis and Thrombosis, Vol. 35, Iss. 5, 2007-01 ,pp. : 405-407

Karger

Access to resources Recommend Favorite